Related references
Note: Only part of the references are listed.Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically
Akinori Sato et al.
BJU INTERNATIONAL (2012)
Proteasome Inhibitors Induce p53-Independent Apoptosis in Human Cancer Cells
Bulbul Pandit et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma
Jiro Kikuchi et al.
BLOOD (2010)
Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma
Kristopher A. Sarosiek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Kaposi's sarcoma and its associated herpesvirus
Enrique A. Mesri et al.
NATURE REVIEWS CANCER (2010)
Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cells
Claudia P. Miller et al.
BLOOD (2009)
HIV-associated lymphomas and gamma-herpesviruses
Antonino Carbone et al.
BLOOD (2009)
Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
Xavier Contreras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Kaposi's Sarcoma-Associated Herpesvirus K-bZIP Protein Is Necessary for Lytic Viral Gene Expression, DNA Replication, and Virion Production in Primary Effusion Lymphoma Cell Lines
Sylvain Lefort et al.
JOURNAL OF VIROLOGY (2009)
Viral avoidance and exploitation of the ubiquitin system
Felix Randow et al.
NATURE CELL BIOLOGY (2009)
Acetylation is indispensable for p53 activation
Yi Tang et al.
CELL (2008)
A case of HIV-negative primary effusion lymphoma treated with bortezomib, pegylated liposomal doxorubicin, and rituximab
Tanya Siddiqi et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
Histone deacetylase inhibitors: molecular mechanisms of action
W. S. Xu et al.
ONCOGENE (2007)
Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen
D. Bubman et al.
ONCOGENE (2007)
Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation
Jianyong Liu et al.
JOURNAL OF VIROLOGY (2007)
Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas
Grzegorz Sarek et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Apoptosis induced by proteasome inhibition in cancer cells:: predominant role of the p53/PUMA pathway
C. G. Concannon et al.
ONCOGENE (2007)
Virus-associated tumor imaging by induction of viral gene expression
De-Xue Fu et al.
CLINICAL CANCER RESEARCH (2007)
p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitors
Duonan Yu et al.
BLOOD (2007)
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: A cell and animal model of virally induced Kaposi's sarcoma
Agata D'Agostino Mutlu et al.
CANCER CELL (2007)
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Esther A. Obeng et al.
BLOOD (2006)
NF-κB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo
SA Keller et al.
BLOOD (2006)
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status
P Perez-Galan et al.
BLOOD (2006)
Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS
E Boulanger et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The targeting of primary effusion lymphoma cells for apoptosi by inducing lytic replication of human herpesvirus 8 while blocking virus production
CM Klass et al.
BLOOD (2005)
The proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells
H Matta et al.
CANCER BIOLOGY & THERAPY (2005)
The tumor microenvironment controls primary effusion lymphoma growth in vivo
MR Staudt et al.
CANCER RESEARCH (2004)
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
A Ito et al.
EMBO JOURNAL (2002)
Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-α
FY Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50
Y Gwack et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
